Skip To Main Content
J. Barrette on Muck Rack

J. Barrette

As seen in: Canadian Journal of Cardiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with J.

Contact J., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

LESS LONG-TERM MIGRAINE IN CHILDREN FOLLOWING OCCLUTECH PERCUTANEOUS ATRIAL SEPTAL DEFECT CLOSURE VS THE AMPLATZ

|
By A. Boismenu, J. Barrette, V. Lieu, N. Dahdah
| Canadian Journal of Cardiology Verified
BACKGROUND Percutaneous closure of secundum atrial septal defect (ASD) is associated with an exacerbation of pre-existing migraine symptoms and the onset of de novo migraines that normally resolve within 3 months after the procedure. Few studies address the possible persistence of long-term symptoms, particularly in the pediatric population and none compares the occluding device used. At the CHU Ste-Justine, ASD closure is exclusively percutaneous, using either Amplatz or Occlutech occluders.
Open in Who Shared Issue with article?
See all 1 articles